2-[2,4-dioxo-3-(piperidin-1-ylmethyl)-1,3-thiazolidin-5-yl]-N-phenylacetamide结构式
|
常用名 | 2-[2,4-dioxo-3-(piperidin-1-ylmethyl)-1,3-thiazolidin-5-yl]-N-phenylacetamide | 英文名 | 2-[2,4-dioxo-3-(piperidin-1-ylmethyl)-1,3-thiazolidin-5-yl]-N-phenylacetamide |
|---|---|---|---|---|
| CAS号 | 314260-14-5 | 分子量 | 347.4 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C17H21N3O3S | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | 2-[2,4-dioxo-3-(piperidin-1-ylmethyl)-1,3-thiazolidin-5-yl]-N-phenylacetamide |
|---|
| 分子式 | C17H21N3O3S |
|---|---|
| 分子量 | 347.4 |
| InChIKey | SHYRSIYFQRVXHH-UHFFFAOYSA-N |
| SMILES | C1CCN(CC1)CN2C(=O)C(SC2=O)CC(=O)NC3=CC=CC=C3 |
|
实验名称:High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i ...
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id:HMS1303
|